4
Changes in Ownership
Candel Therapeutics, Inc. Filed Acc 0000950170-25-021283
Options or other derivatives
- Chief Executive Officer acquired 525,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Tak Paul Peter Chief Executive Officer | 2025-02-12 | Grant or award · Stock Option (Right to Buy) | +525,000 | 525,000 | D: show line 1 in the form |
Loading xslF345X05/ownership.xml…